Clinical Trials Browser

Phase 2 × Kidney Neoplasms × carfilzomib × Clear all

NCT01775930 2020-03-04

Carfilzomib in Refractory Renal Cell Carcinoma (RCC)

Phase 2 Completed

10 enrolled 13 charts

Carcinoma, Renal Cell, Kidney Neoplasms